Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CellSource Co., Ltd. ( (JP:4880) ) has provided an update.
CellSource Co., Ltd. has announced its decision to transition from the Prime Market to the Standard Market of the Tokyo Stock Exchange. This strategic move is aimed at enhancing corporate value over the medium to long term by optimizing management resources and strengthening corporate governance, while continuing to meet stakeholder expectations.
The most recent analyst rating on (JP:4880) stock is a Hold with a Yen547.00 price target. To see the full list of analyst forecasts on CellSource Co., Ltd. stock, see the JP:4880 Stock Forecast page.
More about CellSource Co., Ltd.
Average Trading Volume: 75,523
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen9.55B
For an in-depth examination of 4880 stock, go to TipRanks’ Overview page.